DANIMER SCIENTIFIC INC (DNMR) Fundamental Analysis & Valuation

NYSE:DNMR • US2362721001

4.13 USD
-0.59 (-12.5%)
Last: Dec 30, 2024, 08:08 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DNMR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, DNMR scores 2 out of 10 in our fundamental rating. DNMR was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of DNMR have multiple concerns. DNMR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. DNMR Profitability Analysis

1.1 Basic Checks

  • DNMR had negative earnings in the past year.
  • DNMR had a negative operating cash flow in the past year.
  • In the past 5 years DNMR always reported negative net income.
  • DNMR had a negative operating cash flow in each of the past 5 years.
DNMR Yearly Net Income VS EBIT VS OCF VS FCFDNMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

  • DNMR's Return On Assets of -17.27% is on the low side compared to the rest of the industry. DNMR is outperformed by 88.10% of its industry peers.
  • DNMR has a worse Return On Equity (-52.55%) than 86.90% of its industry peers.
Industry RankSector Rank
ROA -17.27%
ROE -52.55%
ROIC N/A
ROA(3y)-18.22%
ROA(5y)-11.26%
ROE(3y)-38.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DNMR Yearly ROA, ROE, ROICDNMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -10 -20 -30 -40 -50

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DNMR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DNMR Yearly Profit, Operating, Gross MarginsDNMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DNMR Health Analysis

2.1 Basic Checks

  • DNMR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DNMR has been increased compared to 1 year ago.
  • DNMR has a worse debt/assets ratio than last year.
DNMR Yearly Shares OutstandingDNMR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
DNMR Yearly Total Debt VS Total AssetsDNMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

  • DNMR has an Altman-Z score of -1.42. This is a bad value and indicates that DNMR is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.42, DNMR is doing worse than 85.71% of the companies in the same industry.
  • A Debt/Equity ratio of 1.80 is on the high side and indicates that DNMR has dependencies on debt financing.
  • DNMR's Debt to Equity ratio of 1.80 is on the low side compared to the rest of the industry. DNMR is outperformed by 84.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Altman-Z -1.42
ROIC/WACCN/A
WACC5.84%
DNMR Yearly LT Debt VS Equity VS FCFDNMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

  • DNMR has a Current Ratio of 3.28. This indicates that DNMR is financially healthy and has no problem in meeting its short term obligations.
  • DNMR's Current ratio of 3.28 is amongst the best of the industry. DNMR outperforms 86.90% of its industry peers.
  • DNMR has a Quick Ratio of 2.05. This indicates that DNMR is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.05, DNMR is doing good in the industry, outperforming 77.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.28
Quick Ratio 2.05
DNMR Yearly Current Assets VS Current LiabilitesDNMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DNMR Growth Analysis

3.1 Past

  • The earnings per share for DNMR have decreased strongly by -825.53% in the last year.
  • DNMR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.71%.
  • The Revenue has been decreasing by -0.46% on average over the past years.
EPS 1Y (TTM)-825.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1130.77%
Revenue 1Y (TTM)-26.71%
Revenue growth 3Y-0.46%
Revenue growth 5YN/A
Sales Q2Q%-21.17%

3.2 Future

  • DNMR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.49% yearly.
  • The Revenue is expected to grow by 52.38% on average over the next years. This is a very strong growth
EPS Next Y-2009.57%
EPS Next 2Y-258.17%
EPS Next 3Y-108.23%
EPS Next 5Y18.49%
Revenue Next Year-18.56%
Revenue Next 2Y31.78%
Revenue Next 3Y53.32%
Revenue Next 5Y52.38%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DNMR Yearly Revenue VS EstimatesDNMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
DNMR Yearly EPS VS EstimatesDNMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40

More info and screens

Find the best growth stocksShow best growing peers

0

4. DNMR Valuation Analysis

4.1 Price/Earnings Ratio

  • DNMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DNMR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DNMR Price Earnings VS Forward Price EarningsDNMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DNMR Per share dataDNMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as DNMR's earnings are expected to decrease with -108.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-258.17%
EPS Next 3Y-108.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DNMR Dividend Analysis

5.1 Amount

  • DNMR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

DNMR Fundamentals: All Metrics, Ratios and Statistics

DANIMER SCIENTIFIC INC

NYSE:DNMR (12/30/2024, 8:08:00 PM)

4.13

-0.59 (-12.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-19
Earnings (Next)N/A
Inst Owners31.85%
Inst Owner Change-15.78%
Ins Owners9.26%
Ins Owner Change0%
Market Cap12.47M
Revenue(TTM)37.43M
Net Income(TTM)-111.20M
Analysts45
Price Target4.76 (15.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.58%
Min EPS beat(2)19.01%
Max EPS beat(2)42.14%
EPS beat(4)4
Avg EPS beat(4)15.98%
Min EPS beat(4)0.17%
Max EPS beat(4)42.14%
EPS beat(8)6
Avg EPS beat(8)7.58%
EPS beat(12)6
Avg EPS beat(12)-34.15%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.33%
Min Revenue beat(2)-19.32%
Max Revenue beat(2)-1.34%
Revenue beat(4)0
Avg Revenue beat(4)-8.85%
Min Revenue beat(4)-19.32%
Max Revenue beat(4)-1.34%
Revenue beat(8)0
Avg Revenue beat(8)-12.4%
Revenue beat(12)0
Avg Revenue beat(12)-14.21%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.15%
PT rev (3m)449.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3326.05%
EPS NY rev (1m)1.92%
EPS NY rev (3m)-3781.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-53.05%
Revenue NY rev (1m)3.66%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.09
EV/EBITDA N/A
EPS(TTM)-13.05
EYN/A
EPS(NY)-19.5
Fwd EYN/A
FCF(TTM)-23.79
FCFYN/A
OCF(TTM)-20.66
OCFYN/A
SpS12.39
BVpS70.06
TBVpS44.98
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.27%
ROE -52.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.22%
ROA(5y)-11.26%
ROE(3y)-38.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.81%
Cap/Sales 25.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.28
Quick Ratio 2.05
Altman-Z -1.42
F-Score2
WACC5.84%
ROIC/WACCN/A
Cap/Depr(3y)829.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)227.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-825.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1130.77%
EPS Next Y-2009.57%
EPS Next 2Y-258.17%
EPS Next 3Y-108.23%
EPS Next 5Y18.49%
Revenue 1Y (TTM)-26.71%
Revenue growth 3Y-0.46%
Revenue growth 5YN/A
Sales Q2Q%-21.17%
Revenue Next Year-18.56%
Revenue Next 2Y31.78%
Revenue Next 3Y53.32%
Revenue Next 5Y52.38%
EBIT growth 1Y29.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.81%
EBIT Next 3Y27.74%
EBIT Next 5Y24.28%
FCF growth 1Y75.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.65%
OCF growth 3YN/A
OCF growth 5YN/A

DANIMER SCIENTIFIC INC / DNMR FAQ

What is the fundamental rating for DNMR stock?

ChartMill assigns a fundamental rating of 2 / 10 to DNMR.


Can you provide the valuation status for DANIMER SCIENTIFIC INC?

ChartMill assigns a valuation rating of 0 / 10 to DANIMER SCIENTIFIC INC (DNMR). This can be considered as Overvalued.


Can you provide the profitability details for DANIMER SCIENTIFIC INC?

DANIMER SCIENTIFIC INC (DNMR) has a profitability rating of 0 / 10.